Biocryst Pharmaceuticals Inc (BCRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BCRX? Forum Prognose

Finanzdaten der Biocryst Pharmaceuticals Inc-Aktie (BCRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.69% 92.76	93.40	86.74	82.49	68.78
Cost Of Revenue	18.75% 1.265	1.557	1.099	0.894	0.931
Gross Profit	0.38% 91.50	91.84	85.64	81.60	67.85
Operating Expenses	21.21% 105.98	134.51	97.56	102.30	96.26
Interest Income/Expense	0.31% 24.51	24.58	27.34	28.91	27.40
Benefits Costs and Expenses	18.39% 127.78	156.56	122.56	157.08	121.44
Costs And Expenses	21.18% 107.25	136.07	98.66	103.19	97.19
Operating Income/Loss	66.05% -14.49	-42.67	-11.92	-20.70	-28.41
Income/Loss From Continuing Operations Before Tax	44.56% -35.01	-63.16	-35.82	-74.59	-52.66
Income Tax Expense/Benefit	125.51% 0.365	-1.431	0.33	0.74	0.671
Income/Loss From Continuing Operations After Tax	42.69% -35.38	-61.73	-36.15	-75.33	-53.33
Net Income/Loss	42.69% -35.38	-61.73	-36.15	-75.33	-53.33
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	6,541% 206.06	3.103	189.64	189.12	188.51
Diluted Average Shares	6,541% 206.06	3.103	189.64	189.12	188.51
Basic Earnings Per Share	45.16% -0.17	-0.31	-0.19	-0.40	-0.28
Diluted Earnings Per Share	45.16% -0.17	-0.31	-0.19	-0.40	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%